Collectively, our findings delineated multiple molecular perturbations are responsible for epigenetic silencing of RARRES1, in the light of the tumor microenvironmental effect, DNA methylation, CTCF binding, as well as histone modifications. The gene discussed is CTCF; the disease is neoplasm.